-
1دورية أكاديمية
المؤلفون: Buket Altinok Gunes, Yalda Hekmatshoar, Tulin Ozkan, Sureyya Bozkurt, O.Sena Aydos, Yahya Buyukasik, Elifcan Aladag, Asuman Sunguroglu
المصدر: Mediterranean Journal of Hematology and Infectious Diseases, Vol 15, Iss 1 (2023)
مصطلحات موضوعية: CML, Imatinib resistance, BCR-ABL mutations, sCD-1, Diseases of the blood and blood-forming organs, RC633-647.5
وصف الملف: electronic resource
العلاقة: http://www.mjhid.org/index.php/mjhid/article/view/5171Test; https://doaj.org/toc/2035-3006Test
-
2دورية أكاديمية
المؤلفون: Altınok Güneş, Buket, Hekmatshoar, Yalda, Özkan, Tülin, Bozkurt, Süreyya, Erdoğan Aydos, O. Sena, Büyükaşık, Yahya, Aladağ, Elifcan, Sunguroğlu, Asuman
المساهمون: Hekmatshoar, Yalda
مصطلحات موضوعية: BCR-ABL Mutations, CML, Imatinib Resistance, SCD-1
وصف الملف: application/pdf
العلاقة: Mediterranean Journal of Hematology and Infectious Diseases; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Altınok Güneş, B., Hekmatshoar, Y., Özkan, T., Bozkurt, S., Erdoğan Aydos, O. S., Büyükaşık, Y., Aladağ, E., Sunguroğlu, A. (2023). Downregulation of stearoyl-CoA desaturase 1 (SCD-1) promotes resistance to imatinib in chronic Myeloid Leukemia. Mediterranean Journal of Hematology and Infectious Diseases, 15(1).; https://hdl.handle.net/20.500.12939/3196Test; 15
-
3دورية أكاديمية
المؤلفون: Liuya Wei, Yang Yang, Pranav Gupta, Aihong Wang, Min Zhao, Yao Zhao, Mei Qu, Yu Ke, Ying Liu, Hong-Min Liu, Xin Xu, Yanli Sun, Zhe-Sheng Chen, Zhenbo Hu
المصدر: Molecular Therapy: Oncolytics, Vol 18, Iss , Pp 137-148 (2020)
مصطلحات موضوعية: chronic myeloid leukemia, imatinib resistance, BCR-ABL kinase, targeted therapies, cell differentiation, BCR-ABL mutations, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S2372770520300875Test; https://doaj.org/toc/2372-7705Test
-
4دورية أكاديمية
المؤلفون: Zafar Iqbal, Tanveer Akhtar, Ahmad M Khalid, Aamer Aleem, Amer Mahmood, Afia M Akram, Mahmood Rasool, Ijaz H Shah, Aysha Bhalli, Muhammad Khalid, Mudassar Iqbal, Abid Jameel, Nawaf Al-Anazi
المصدر: Journal of Applied Hematology, Vol 11, Iss 3, Pp 108-111 (2020)
مصطلحات موضوعية: chronic myeloid leukemia, compound bcr-abl mutations, interferon, pan-tyrosine kinase inhibitor resistance, ponatinib resistance, Diseases of the circulatory (Cardiovascular) system, RC666-701
وصف الملف: electronic resource
العلاقة: http://www.jahjournal.org/article.asp?issn=1658-5127;year=2020;volume=11;issue=3;spage=108;epage=111;aulast=IqbalTest; https://doaj.org/toc/1658-5127Test
-
5دورية أكاديمية
المؤلفون: Radowan Elnair, Ahmed Galal
المصدر: BMC Cancer, Vol 18, Iss 1, Pp 1-5 (2018)
مصطلحات موضوعية: Chronic myeloid leukemia, Nilotinib, Drug-resistant BCR-ABL mutations, V299L, Dasatinib, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: http://link.springer.com/article/10.1186/s12885-018-5004-3Test; https://doaj.org/toc/1471-2407Test
-
6دورية أكاديمية
المؤلفون: Giuseppe Pietrantuono
المصدر: Clinical Management Issues, Vol 7, Iss 1S, Pp 13-17 (2015)
مصطلحات موضوعية: Nilotinib, Chronic myeloid leukemia, Imatinib resistance, BCR-ABL mutations Keywords: Nilotinib, BCR-ABL mutations, Medicine (General), R5-920
وصف الملف: electronic resource
العلاقة: https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1143Test; https://doaj.org/toc/1973-4832Test; https://doaj.org/toc/2283-3137Test
-
7دورية أكاديمية
المؤلفون: Ferdinando Porretto
المصدر: Clinical Management Issues, Vol 5, Iss 6S, Pp 11-16 (2015)
مصطلحات موضوعية: Sub-optimal responder, Nilotinib, Imatinib, BCR-ABL mutations, Medicine (General), R5-920
وصف الملف: electronic resource
العلاقة: https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1133Test; https://doaj.org/toc/1973-4832Test; https://doaj.org/toc/2283-3137Test
-
8دورية أكاديمية
المؤلفون: Luigia Luciano
المصدر: Clinical Management Issues, Vol 4, Iss 5S, Pp 15-18 (2015)
مصطلحات موضوعية: Chronic myeloid leukemia, Imatinib resistance, BCR-ABL mutations, Nilotinib, Medicine (General), R5-920
وصف الملف: electronic resource
العلاقة: https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1093Test; https://doaj.org/toc/1973-4832Test; https://doaj.org/toc/2283-3137Test
-
9دورية أكاديمية
المؤلفون: E. G. Ovsyannikova, K. D. Kaplanov, T. Yu. Klitochenko, A. V. Misyurin, I. L. Davydkin, L. V. Zaklyakova, E. A. Popov, B. N. Levitan
المصدر: Онкогематология, Vol 7, Iss 4, Pp 16-23 (2014)
مصطلحات موضوعية: chronic myeloid leukemia, BCR-ABL mutations, resistance, imatinib, Diseases of the blood and blood-forming organs, RC633-647.5
وصف الملف: electronic resource
-
10دورية أكاديمية
المؤلفون: Pietrantuono, Giuseppe
المصدر: Clinical Management Issues; Vol 7, No 1S (2013); 13-17 ; 2283-3137
مصطلحات موضوعية: Clinical Medicine, Nilotinib, Chronic myeloid leukemia, Imatinib resistance, BCR-ABL mutations Keywords: Nilotinib, BCR-ABL mutations
وصف الملف: text/html; application/pdf
العلاقة: http://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1143/1356Test; http://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1143/1357Test; http://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1143Test
الإتاحة: https://doi.org/10.7175/cmi.v7i1S.1143Test
http://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1143Test
النص الكامل